| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Ping An Biomedical signs distribution deal with health services firm | 1 | Investing.com | ||
| PING AN BIOMEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | Ping An Biomedical Co., Ltd: Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years | 133 | GlobeNewswire (Europe) | HONG KONG, July 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (hereinafter referred to as "Ping An Biomedical") announced that it has formally signed a strategic cooperation... ► Artikel lesen | |
| Mo | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 27.05. | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 19.03. | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 5 | SEC Filings | ||
| 19.03. | Aktionäre von Ping An Biomedical genehmigen duale Aktienstruktur | 1 | Investing.com Deutsch | ||
| 19.03. | Ping An Biomedical shareholders approve dual-class share structure | 1 | Investing.com | ||
| 19.03. | Ping An Biomedical Co., Ltd: All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital | 235 | GlobeNewswire (Europe) | HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that shareholders have approved all five resolutions at... ► Artikel lesen | |
| 09.03. | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13.02. | Ping An Biomedical Co., Ltd. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 12.02. | Ping An Biomedical Co., Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.01. | Ping An Biomedical Co., Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 09.01. | Ping An Biomedical Co., Ltd.: Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry | 694 | GlobeNewswire (Europe) | HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the... ► Artikel lesen | |
| 09.01. | Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation | 353 | GlobeNewswire (Europe) | HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") today announced that it has entered into a series of share purchase... ► Artikel lesen | |
| 28.11.25 | Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter | 211 | GlobeNewswire (Europe) | Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the "Company") today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025... ► Artikel lesen | |
| 12.09.25 | Majestic Ideal Holdings Ltd. Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting | 426 | GlobeNewswire (Europe) | HONG KONG, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Ltd (NASDAQ: MJID) (the "Company") announced that during the Extraordinary General Meeting of Shareholders (the "Meeting") held... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,800 | +2,22 % | Fresenius hinter Siemens Energy und RWE auf Platz 3 im DAX - startet die Aktie jetzt wieder ... | Die Aktie von Fresenius gehört heute zu den stärksten Titeln des Tages im deutschen Leitindex DAX. Hinter Siemens Energy und RWE rangiert Fresenius auf Rang drei mit einem Plus von 2,1 Prozent auf 42... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,060 | +3,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,270 | +0,65 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,430 | 0,00 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 72,91 | -0,01 % | BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? | ||
| AVEANNA HEALTHCARE | 9,450 | 0,00 % | Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy? | ||
| CARL ZEISS MEDITEC | 27,800 | +1,68 % | Carl Zeiss Meditec, Jost Werke: frische Shortpositionen - bei Deutz wie Symrise Fonds auf Rückzug | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert, unterliegt Transparenzpflichten gemäß EU-Leerverkaufsverordnung. Ab einer Netto-Leerverkaufsposition von 0,5 Prozent des ausgegebenen Aktienkapitals... ► Artikel lesen | |
| GERRESHEIMER | 26,280 | -0,90 % | EQS-News: Gerresheimer AG: Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in Betrieb | EQS-News: Gerresheimer AG
/ Schlagwort(e): Expansion
Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in Betrieb
23.07.2026 / 10:00 CET/CEST
Für den Inhalt... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 16,680 | -0,06 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BILLIONTOONE | 126,07 | -0,01 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| ADVANCED BIOMED | 18,980 | 0,00 % | Morning Market Movers: InMed Pharmaceuticals, INLIF Limited, China SXT Pharmaceuticals, Advanced Biomed See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| GENEDX | 59,07 | -0,05 % | NSE - GeneDx Holdings Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| PRIVIA HEALTH GROUP | 25,500 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| PROGYNY | 31,190 | 0,00 % | Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report | ||
| LIFESTANCE HEALTH GROUP | 10,885 | -0,14 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen |